India’s direct-to-consumer (D2C) healthcare market is entering a phase of structural maturity. Earlier growth driven by marketing and rapid customer acquisition has shifted toward outcome-oriented consumption, product efficacy, and regulatory awareness.¹ ² By 2025, both investors and consumers began prioritizing measurable health benefits, transparency in formulations, and sustainable business models.¹ ²
D2C healthcare startups in India are direct-to-consumer health brands that sell nutrition, diagnostics, or preventive care products directly to consumers without intermediaries.
India’s nutraceutical market, a key segment within direct-to-consumer healthcare in India, was estimated at over USD 20 billion in 2025 and is projected to grow steadily in the coming years, reflecting strong demand for preventive and nutrition-based health solutions.³
Globally, pharmaceutical and healthcare companies are also exploring D2C channels to improve patient engagement, adherence, and access to care, indicating a broader structural shift in healthcare delivery.⁴⁵ This trend is reflected in India, where digital-first, fast-growing D2C healthcare startups in India are building direct relationships with consumers while operating within regulatory frameworks.
Unlike the dominant Ayurvedic wellness segment, these consumer health brands in India rely on modern nutrition science and globally studied ingredients.
Within this landscape, a new cohort of fast-growing D2C healthcare startups in India has emerged. These companies, including several nutrition startups India is seeing today, primarily operate in nutraceuticals and functional nutrition, focusing on scientifically supported ingredients rather than traditional or alternative medicine systems. Their products are regulated under the Food Safety and Standards Authority of India (FSSAI) as health supplements, and they avoid disease-treatment claims that would require approval from the Central Drugs Standard Control Organisation (CDSCO).⁶
Most formulations are based on ingredient-level evidence rather than product-level randomized clinical trials, which remains an important distinction when evaluating efficacy. This also highlights the need for stronger clinical validation to establish consistent consumer health outcomes.
The following under-the-radar brands illustrate this shift toward evidence-aligned, consumer-facing healthcare.
Here are five under-the-radar D2C healthcare startups in India to watch in 2026.
Focus: Women’s health supplements including PCOS, menopause, and general nutrition
Earthful was founded by Veda and Sudha Gogineni to address nutritional gaps in women’s health. The company develops plant-based supplements targeting conditions such as PCOS, sleep disturbances, and hormonal imbalance.⁷
Its formulations include ingredients such as myo-inositol and chromium. Clinical evidence suggests that myo-inositol supplementation may improve insulin sensitivity and menstrual regularity in women with PCOS, supporting the biological rationale of such products.⁸
In 2025, Earthful raised ₹26 crore in funding led by Fireside Ventures and others.⁷ The company reported over 200,000 customers, indicating growing demand for preventive women’s health solutions delivered through D2C channels.
Focus: Foundational nutrition and micronutrient supplementation
Supply6 positions itself as a science-led nutrition company addressing everyday dietary deficiencies. Its flagship product, Supply6 360, contains a combination of over 60 nutrients including vitamins, minerals, probiotics, and plant extracts.
Micronutrient deficiencies remain a significant public health issue in India, with widespread deficiencies in vitamin B12, vitamin D, and iron reported in national surveys. This provides a strong public health basis for such formulations.
The company raised approximately $1.1 million in seed funding in 2025.⁹ Investors have highlighted its science-led positioning and focus on preventive health.⁹ The brand reports over 200,000 customers and a repeat purchase rate of around 45 percent, suggesting sustained consumer engagement.
Focus: Sports nutrition including protein, creatine, and performance supplements
BeastLife operates in the sports nutrition segment, offering whey protein, creatine, and mass gainers through a D2C model. These ingredients are among the most extensively studied in sports nutrition literature.
Evidence shows that whey protein supports muscle protein synthesis, while creatine supplementation improves strength and lean body mass when combined with resistance training.¹⁰
The company raised ₹20 crore in 2026 at a valuation of ₹320 crore.¹¹ It reported revenue growth from approximately ₹36 crore in FY2025 to ₹100 crore in FY2026, reflecting rapid adoption of performance nutrition products in India.
Focus: Everyday nutrition including protein, fiber, collagen, and sugar alternatives
TruNativ develops clean-label nutrition products designed for daily consumption. Its portfolio includes whey and plant protein powders, soluble fiber supplements, collagen peptides, and low-calorie sweeteners.¹²
Collagen supplementation has shown potential benefits in skin elasticity and joint health in controlled studies, while dietary fiber intake is associated with improved metabolic and gastrointestinal outcomes. Considerations such as bioavailability and dosage standardization remain important when translating these benefits into real-world use.
The company has demonstrated steady growth, with revenue increasing from ₹16.6 crore in FY2024 to ₹37.7 crore in FY2025, and crossing ₹65 crore by late 2025.¹² It emphasizes formulation quality, ingredient sourcing, and repeat consumption as key drivers of growth.
See also: Do Peptides Improve Workout Performance? A Nutrition Expert Explains the Science
Focus: Food fortification through nutrient-enriched mixes
Good Monk takes a food-based approach to nutrition by offering tasteless mixes that can be added to everyday meals. These products contain combinations of vitamins, minerals, protein, and fiber.
This model aligns with global public health strategies that promote food fortification as a scalable solution to micronutrient deficiencies.
The company raised ₹33 crore in 2026 at a valuation of ₹175 crore.¹³ It reported rapid growth and expanded distribution across online marketplaces. Its products are positioned as preventive nutrition tools rather than therapeutic interventions.
In India, most D2C nutrition products are classified as nutraceuticals under FSSAI regulations. These products are permitted to support health but cannot claim to diagnose, treat, or cure diseases.⁶
If such claims are made, products fall under the jurisdiction of CDSCO and must comply with drug approval pathways.⁶ This distinction defines how D2C healthcare brands position their offerings in the market.
Recent industry analyses indicate that D2C healthcare is becoming a viable distribution and engagement channel globally. Pharmaceutical companies are increasingly adopting D2C strategies to improve patient adherence, data collection, and personalized care delivery.⁴ ⁵
D2C models also enable direct patient data collection, personalized recommendations, and improved adherence tracking, linking commercial models with clinical outcomes.⁴
In India, this shift is reflected in the rise of digital-first health tech D2C India companies that combine consumer access with evidence-based nutrition and clinically informed formulations. The focus has moved from rapid scaling to sustainable growth driven by product performance and consumer trust.¹ ²
Health and wellness D2C brands are also investing more in research, formulation validation, and transparency as competitive differentiators.²
The D2C healthcare segment in India is transitioning from a marketing-driven model to one grounded in scientific rationale and measurable outcomes.
However, variability in product quality and lack of standardized clinical validation remain ongoing concerns in the segment.
Brands such as Earthful, Supply6, BeastLife, TruNativ, and Good Monk illustrate how consumer healthcare is evolving toward preventive, nutrition-focused solutions delivered directly to users.
As the sector matures, long-term credibility will depend on clinical validation, regulatory compliance, and the ability to demonstrate real-world health impact.
The next phase of D2C healthcare in India will likely be defined not by product launches, but by clinical validation and regulatory scrutiny.
Indian Retailer. “Beyond Growth: How Indian D2C Brands Redefined Credibility in 2025.”
https://indianretailer.com/article/retail-business/eretail/beyond-growth-how-indian-d2c-brands-redefined-credibility-2025
Inc42. “Decoding the Growth of Indian Health & Wellness D2C Brands.”
https://inc42.com/resources/decoding-the-growth-of-indian-health-wellness-d2c-brands/
OMR Global. “Indian Nutraceuticals Market Size to Reach $48.9 Billion by 2035.”
https://www.omrglobal.com/press-release/indian-nutraceuticals-market-share
EY. “Why It’s Time for a Digital Direct-to-Consumer Health Care Revolution.”
https://www.ey.com/en_hu/alliances/why-its-time-for-a-digital-direct-to-consumer-health-care-revolution
eMarketer. “D2C Will Become a Viable Distribution Channel for Healthcare.”
https://www.emarketer.com/content/d2c-will-become-viable-distribution-channel-healthcare-pharma-companies-2025
PharmaNow. “Understanding Nutraceuticals Regulations in India.”
https://www.pharmanow.live/knowledge-hub/research/nutraceuticals-regulation-challenges-india
Economic Times. “Plant-Based Nutrition Brand Earthful Raises $2.8 Million.”
https://economictimes.indiatimes.com/tech/funding/plant-based-nutrition-brand-earthful-raises-2-8-million/articleshow/125889938.cms
Biomedical and Biotechnology Research Journal.
https://journals.lww.com/bbrj/fulltext/2023/07010/effects_of_chromium,_inositol_and_resistant_starch.5.aspx
Indian Retailer. “Supply6 Raises $1.1 Mn Seed Funding.”
https://indianretailer.com/news/funding-alert-supply6-raises-11-mn-seed-funding-led-zeropearl-vc
Kreider, Richard B., et al. “International Society of Sports Nutrition Position Stand: Creatine Supplementation.”
https://jissn.biomedcentral.com/articles/10.1186/s12970-017-0173-z
Entrepreneur India. “BeastLife Raises INR 20 Cr.”
https://www.entrepreneurindia.com/blog/en/news/d2c-nutrition-brand-beastlife-raises-inr-20-cr-in-new-round.59748
Inc42. “How TruNativ Is Winning By Making Health Effortless.”
https://inc42.com/startups/how-this-daily-nutrition-brand-is-winning-by-making-health-effortless/
Inc42. “Good Monk Raises ₹33 Cr.”
https://inc42.com/buzz/d2c-nutrition-brand-good-monk-raises-33-cr/